Eruption as a Clinical Manifestation of COVID-19: Photographs of a Patient
A 26-year-old American graduate student receiving adalimumab biweekly (at a dose of 40 mg, citrate-free, with the pen kit and no other medications) for Crohn’s disease in remission had close contact with persons documented to be infected with SARS-CoV-2. On March 13, 2020, he complained of a sore throat followed several days later by malaise, aches, and a mild nonproductive cough, plus loss of taste and smell. There was minimal chest congestion. Thirteen days after the onset of these findings, he developed for the first time a fever of 101°F (38.3°C). The next morning (day 14) he awoke with an asymptomatic facial eruption and consulted both of us through telemedicine.